Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.
LATEST RENAL CELL CARCINOMA CONTENT
Phase 2 Trials Support NCCN’s Inclusion of Combinations for nccRCC
Tailoring TKI Dosing Strategies to Real-World Patients With RCC
Clinical and Logistical Factors Determine Treatment Choice for nccRCC
Oncologists Discuss Choice of Frontline IO/TKI for Metastatic RCC
Non–Clear Cell RCC Trials Support Regimens Approved for Clear Cell RCC
Insurance and Tolerability Factors Considered in Recurrent RCC Treatment
Considering the Impact of Sequencing in Frontline RCC Therapy
Comparing Non–Clear Cell RCC Combination Therapy Options
CASE-BASED ROUNDTABLES
Advertisement
Advertisement
